Heron Therapeutics | Ventes

Sales Changement Date
ALKERMES USD 350.4M 27.08M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Amarin USD 74.71M 8.66M 2023-12
ANI Pharmaceuticals USD 137.4M 5.75M 2024-03
Arrowhead Research USD 50M 46.45M 2024-03
Eisai JPY 177.7B 1.09B 2023-12
GlaxoSmithKline GBP 7.36B 692M 2024-03
Insmed USD 75.5M 8.19M 2024-03
Ligand Pharmaceuticals USD 30.98M 2.88M 2024-03
Merck USD 15.8B 1.17B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
Pacira USD 167.12M 14.12M 2024-03
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Roche Holding CHF 28.94B 842M 2023-12
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
Veracyte USD 96.84M 1.36M 2024-03
Vertex Pharmaceuticals USD 2.69B 172.3M 2024-03



Heron Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.